Oticara, a clinical-stage pharmaceutical company focused on developing innovative therapies for chronic rhinosinusitis (CRS), announced encouraging Phase 2 clinical trial results for its proprietary nasal-mucosa-optimized steroid cream, OT-007B. The therapy demonstrated rapid, durable, and clinically meaningful improvements in patients with…
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel oral small molecule therapies that target STAT3 for the treatment of fibrosis-driven diseases, announced an update on preliminary results from its Phase 2 REVERT clinical trial of TTI-101 in patients with…
A team of scientists at Children’s Hospital Los Angeles (CHLA) has made a major breakthrough in understanding Ewing Sarcoma, a rare and aggressive cancer of the bone and soft tissue that predominantly strikes children and adolescents. Their findings provide compelling…
Arcus Biosciences, Inc., a clinical-stage global biopharmaceutical company focused on developing innovative cancer therapies, announced the first overall survival (OS) results from Arm A1 of its Phase 2 EDGE-Gastric study. The trial evaluates domvanalimab, an Fc-silent anti-TIGIT antibody, in combination…
Zoetis Inc. today announced that the Committee for Veterinary Medicinal Products (CVMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of marketing authorization for Lenivia® (izenivetmab) for the reduction of pain associated with osteoarthritis…
Adagio Medical Holdings, Inc., a leading developer of catheter ablation technologies for cardiac arrhythmias, today announced preliminary acute safety and efficacy results from its FULCRUM-VT study, evaluating Ultralow Temperature Cryoablation (ULTC) for the treatment of Sustained Monomorphic Ventricular Tachycardia (SMVT)…
Joining world-changing breakthroughs such as YouTube, the Apple iPhone, IBM’s Watson, and the Large Hadron Collider, the Double Neural Bypass, a revolutionary brain-computer interface developed at Northwell Health’s Feinstein Institutes for Medical Research, has been inducted into TIME’s Best Inventions…
Satellos Bioscience Inc., a clinical-stage biotechnology company pioneering regenerative treatments for degenerative muscle diseases, has announced compelling new results supporting the safety, tolerability, and early signs of efficacy of its lead candidate, SAT-3247, in adults with Duchenne muscular dystrophy (DMD).…
Wysa, a global leader in AI-guided mental healthcare, has released compelling new research showing that loneliness is far more than an emotional or social issue—it is a serious clinical risk factor with deep implications for both mental and physical health.…
Genethon, a global leader in gene therapy research for rare genetic diseases, and Hansa Biopharma, a Sweden-based biotechnology company pioneering IgG-cleaving enzyme technology, have announced a major milestone in the field of gene therapy. A patient suffering from Crigler–Najjar syndrome,…